Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 243.00
Bid: 244.00
Ask: 247.00
Change: 3.00 (1.25%)
Spread: 3.00 (1.23%)
Open: 244.00
High: 248.00
Low: 237.00
Prev. Close: 240.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

7 Nov 2018 13:00

RNS Number : 6607G
Galliford Try PLC
07 November 2018
 

7 November 2018

 

Galliford Try plc

 

Update on Aberdeen Western Peripheral Route and Current Trading

Galliford Try plc ("Galliford Try" or the "Group"), the housebuilding, regeneration and construction group today issues an update on the Aberdeen Western Peripheral Route ("AWPR") contract and Group trading. This statement covers the period 1 July 2018 to 7 November 2018.

 

On AWPR, the completion date for the final section, including the bridge over the River Don, is now expected to be in December owing to increased complexity and weather delays in implementing repairs to the bridge. As a result of higher than anticipated direct costs, and the further delay to completion, our estimate of the final costs to complete the contract has increased by approximately £20m. The final impact on the Galliford Try's financial results will be determined more importantly by the result of the Group's significant claim, in respect of which the Board continues to pursue constructive discussions with the client.

 

The underlying Construction business continues to trade in line with expectations.

 

Linden Homes continues to make good progress against its strategic targets. Sales rates are lower than levels achieved in FY 2018, but prices and margins remain in line with expectations and the business expects to achieve its targets for the full year.

 

Partnerships & Regeneration is trading strongly in both mixed-tenure and contracting, with continuing strong demand across all regions, backed by resolute political support for this sector.

 

The Group expects to report a FY 2019 pre-exceptional profit before tax in line with previous guidance. Average net debt for FY 2019 is expected to remain in the previously guided range of £170m to £190m before any recoveries in relation to the AWPR contract.

 

This announcement contains inside information.

 

For further enquiries please contact:

 

Galliford Try

Peter Truscott, Chief Executive 01895 855001

Graham Prothero, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

Notice of results

 

Galliford Try will hold its Annual General Meeting at 10:30 am on Friday 9 November 2018 at the offices of CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon Street, London, EC4N 6AF.

 

Galliford Try expects to announce its interim results for the six months to 31 December 2018 on 13 February 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary.

 

Notes to editors

 

Galliford Try is listed on the London Stock Exchange and is a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure projects with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSFLFLDIIT
Date   Source Headline
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.